0001127602-12-016886.txt : 20120515 0001127602-12-016886.hdr.sgml : 20120515 20120515161522 ACCESSION NUMBER: 0001127602-12-016886 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120513 FILED AS OF DATE: 20120515 DATE AS OF CHANGE: 20120515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONNEY MICHAEL W CENTRAL INDEX KEY: 0001219016 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21379 FILM NUMBER: 12844858 MAIL ADDRESS: STREET 1: 65 HAYDEN AVE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUBIST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000912183 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223192085 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-860-8660 MAIL ADDRESS: STREET 1: 65 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-05-13 0000912183 CUBIST PHARMACEUTICALS INC CBST 0001219016 BONNEY MICHAEL W 65 HAYDEN AVENUE LEXINGTON MA 02421 1 1 President and CEO Common Stock 2012-05-13 4 M 0 8000 0 A 143799 D Common Stock 2012-05-14 4 S 0 2927 41.5527 D 140872 D Restricted Stock Units 2012-05-13 4 M 0 8000 0 D 2012-05-13 Common Stock 8000 24000 D Sold pursuant to a 10(b)5-1 Plan Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units. This transaction was executed in multiple trades at prices ranging from $41.55 to $41.56. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected. Each restricted stock unit represents a contingent right to receive one share of Cubist common stock. The restricted stock units vest 25% annually over a four-year period, with the first 25% vesting one year after the grant date. The restricted stock units do not expire. /s/ David W.J. McGirr - Attorney in fact 2012-05-15 EX-24 2 doc1.htm POWER OF ATTORNEY 1/5/2009 7:56:46 PM Michael W Bonney POA

EXHIBIT 24

Cubist Pharmaceuticals Inc

Power of Attorney
for Executing Forms 3, 4 and 5

Know all men by these presents, that the undersigned, director or officer, or both, of Cubist Pharmaceuticals Inc, hereby constitutes and appoints each of Benjamin S. Harshbarger, signing singly, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Cubist Pharmaceuticals Inc (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities of Cubist Pharmaceuticals Inc unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of this 9th day of June, 2008
/s/ Michael W Bonney
Michael W Bonney